跳至主要内容
临床试验/JPRN-UMIN000014946
JPRN-UMIN000014946已完成未知

Evaluation of optimum timing for intravitreal injection of aflibercept for age-related macular degeneration - Evaluation of optimum timing for intravitreal injection of aflibercept for age-related macular degeneration

Faculty of life sciences, Kumamoto university0 个研究点目标入组 40 人开始时间: 2016年7月7日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
40

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
ot applicable 至 ot applicable(—)
性别
All

入选标准

  • 未提供

排除标准

  • Presence of other causes of CNV, including pathologic myopia, ocular histoplasmosis syndrome, angioid streaks, choroidal rupture, or multifocal choroiditis in the study eye. History or clinical evidence of diabetic retinopathy, diabetic macular edema or any other vascular disease affecting the retina, other than AMD, in either eye. Active intraocular inflammation in the study eye. Active ocular or periocular infection in study eye. Uncontrolled glaucoma in the study eye. Prior treatment with anti VEGF therapy in the study eye. History of myocardial infarction or stroke in the past 3 months.

研究者

发起方
Faculty of life sciences, Kumamoto university

相似试验

Evaluation of optimum timing for intravitreal... | 临床试验